Clinical Trial Update: TACE With Lenvatinib Versus Lenvatinib Alone in in First-line Treatment of Advanced HCC [Phase 3]

View source ↗

Summary

Phase 3 trial comparing transarterial chemoembolization (TACE) with lenvatinib versus lenvatinib alone in first-line treatment of advanced hepatocellular carcin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Lenvatinib (lenvatinib)
• Transarterial chemoembolization (TACE)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Advanced Hepatocellular Carcinoma | Phase 3 | Status: UNKNOWN